← Browse by Condition
Medical Condition
hematological malignancies
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2
NCT07122674
Recruiting
18F-Pentixafor PET in Hematologic Malignancies
Enrollment
100 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Enrollment
510 pts
Location
United States, Belgi...
Sponsor
Janssen Research & Development...
NCT05306509
Recruiting
Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology
Enrollment
120 pts
Location
China
Sponsor
Children's Hospital of Fudan U...
NCT06834412
Recruiting
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
Enrollment
120 pts
Location
China
Sponsor
Xijing Hospital
NCT06799195 Phase 2
Recruiting
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Enrollment
126 pts
Location
United States
Sponsor
University of Nebraska
NCT06550102
Recruiting
Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies
Enrollment
1,000 pts
Location
Switzerland
Sponsor
University Children's Hospital...